Leiner Health Products’ reorganization
This article was originally published in The Tan Sheet
Executive Summary
OTC drug, dietary supplement private labeler's reorganization plan approved by Wilmington, Del. bankruptcy Judge Peter Walsh April 15. Prepackaged Chapter 11 filing, which previously received senior bank lender and bondholder approval, calls for restructuring current bank debt into two term loans totaling approximately $243 mil., plus a $20 mil. revolving credit facility. Senior subordinated note holders will receive $15 mil. cash and newly issued preferred stock in exchange for the notes (1"The Tan Sheet" March 11, 2000, p. 6)...
You may also be interested in...
Leiner Reorganization Plan Confirmation Hearing Slated For April
An April 15 hearing is scheduled for confirmation of Leiner Health Products' reorganization plan, filed Feb. 28 in Wilmington, Del. bankruptcy court
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.